metricas
covid
Buscar en
Medicina Clínica
Toda la web
Inicio Medicina Clínica Belimumab, una alternativa útil en el tratamiento de la serositis lúpica
Journal Information
Vol. 157. Issue 5.
Pages 261-262 (September 2021)
Share
Share
Download PDF
More article options
Vol. 157. Issue 5.
Pages 261-262 (September 2021)
Carta al Editor
Belimumab, una alternativa útil en el tratamiento de la serositis lúpica
Belimumab, a useful alternative therapy in systemic lupus erythematosus serositis
Visits
28
Tarek Carlos Salman-Montea,
Corresponding author
tareto4@gmail.com

Autor para correspondencia.
, Irene Carrión-Barberàa, Eva Rodríguez Garcíab
a Servicio de Reumatología, Hospital del Mar/Parc de Salut Mar-Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona, España
b Servicio de Nefrología, Hospital del Mar/Parc de Salut Mar-Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona, España
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics

Article

These are the options to access the full texts of the publication Medicina Clínica
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Medicina Clínica

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos